the capacity of the patient 's peripheral blood mononuclear cells ( pbm ) to develop cytotoxic effector cells directed either against allogeneic cells or against epstein-barr virus ( ebv ) or herpes-simplex virus-1 ( hsv-1 ) -infected syngeneic cells was tested monthly .
C3485979
allogeneic cells
C0007634
cells